跳至主要内容
临床试验/CTRI/2021/02/031214
CTRI/2021/02/031214尚未招募2 期

A Prospective Open labelled non randomized phase II Clinical trial of Sathakuppai Chooranam in the management of Kumba vatham(Periarthritis)

Government Siddha Medical College and Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年2月27日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Reduction of the signs and symptoms of shoulder joint pain

研究概览

简要总结

The study is a prospective Open Labelled phase II non randomized clinical study to evaluate the therapeutic efficacy of Sathakuppai Chooranam in the management of Kumba Vatham(Periarthritis).The trial drug will be administered at the dose of 1g twice a day orally aftert food for 45days in 60 patients.The trial period of 12 months will be carrying out in government Siddha Medical College And Hospital,Palayamkottai,Tirunelveli,Tamilnadu.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
30.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patient having main symptoms of shoulder joint,numbness,wasting in the shoulder region and arms ,restricted movement of upper limbs,loss of abduction&forward flexion,stiffnees of the shoulder joint Diabetes mellitus.

排除标准

  • Age below 29&above 61 Rheumatoid Arthritis Ischemic heart Disease Hypertension Pregnancy and lactating mother Recent Shoulder dislocation Sub acromial bursitis.

结局指标

主要结局

Reduction of the signs and symptoms of shoulder joint pain

时间窗: 45 days

Numbness

时间窗: 45 days

Wasting in the shoulder region and arms

时间窗: 45 days

restricted movement of the upper limbs

时间窗: 45 days

loss of abduction

时间窗: 45 days

loss of forward flexion

时间窗: 45 days

stiffness of the shoulder joint

时间窗: 45 days

次要结局

  • Evaluation of additional effects and siddha parameters changes in Kumba vatham(45 days)

研究者

发起方
Government Siddha Medical College and Hospital
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验